Form D · Other Technology

Vesalius Cardiovascular Inc.

Vancouver, A1 · CIK 0001904804

Offering snapshot reported Aug 29, 2025 · SEC filing

Reported sold
$37.8K
Offering amount: $98.8K
Investors reported
2
Form D · investor count
Minimum accepted
Not reported
Reported outside-investor minimum
First sale
Sep 18, 2023
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Aug 29, 2025Amendment$37,821No comparison2SEC filing
Aug 22, 2025Initial$50,308No comparison1SEC filing
Sep 17, 2024Amendment$37,821$0vs Sep 22, 20232SEC filing
Sep 22, 2023Initial$37,821No comparison2SEC filing
Jan 25, 2022Initial$271,960No comparison2SEC filing

Offering details

Securities
Not reported
Exemptions
Not reported
Duration over one year
Not reported
Business combination
Not reported
Sales commissions
$0
Finders' fees
$0
Form D file number
021-492772
Total remaining to be sold represents 13,650 warrants issued to US Investors, exercisable at CAD$6.00 until August 28, 2026. Does not include securities offered or sold under Reg S. Canadian dollars converted to USD at exchange rate of 1.3426.

Source: Form D, filed Aug 29, 2025. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Vincent Ledoux Director, Executive
Peter Skarsgard Director, Executive

Issuer details

Industry: Other Technology (See others in industry)

Address:
200 210 West Broadway
Vancouver, A1, V5Y 3W2